Sigma Planning Corp’s Ascendis Pharma A/S ASND Stock Holding History

Sigma Planning Corp’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.43M	Buy	6,257 +3,967	+173%	+$1M	0.04%	458
2026 Q2	$611K	Sell	2,290 -5,007	-69%	-$1.17M	0.02%	826
2026 Q1	$1.67M	Buy	7,297 +2,513	+53%	+$563K	0.05%	387
2025 Q4	$1.02M	Sell	4,784 -2,820	-37%	-$582K	0.03%	525
2025 Q3	$1.51M	Buy	7,604 +3,500	+85%	+$653K	0.04%	398
2025 Q2	$708K	Buy	4,104 +2,589	+171%	+$422K	0.02%	639
2025 Q1	$236K	Buy	+1,515	New	+$216K	0.01%	1052

Other funds holding ASND

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Henry James International Management New York $330M AUM 35.5% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Sigma Planning Corp's ASND Position: Q3 2026 in Review

Sigma Planning Corp increased its Ascendis Pharma A/S (ASND) stake by 173% in Q3 2026, buying an estimated $1M and bringing the position to 6,257 shares worth $1.43M. The position accounts for 0.04% of the portfolio, ranked #458.

Sigma Planning Corp first reported a position in ASND in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.67M in Q1 2026. 43 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Sigma Planning Corp held 6,257 shares of Ascendis Pharma A/S worth $1.43M as of Q3 2026.
Sigma Planning Corp bought 3,967 Ascendis Pharma A/S shares in Q3 2026, an estimated $1M.
Ascendis Pharma A/S made up 0.04% of Sigma Planning Corp's portfolio in Q3 2026, its #458 holding.
Sigma Planning Corp first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 7 quarters since.
Sigma Planning Corp's Ascendis Pharma A/S position peaked at $1.67M in Q1 2026.
43 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.